IJT - ETF AI Analysis
Top Page
iShares S&P Small-Cap 600 Growth ETF (IJT)
IJT, the iShares S&P Small-Cap 600 Growth ETF, has a solid overall rating driven by several strong holdings like Alkermes, Zurn Water Solutions, Federal Signal, and Armstrong World, which show robust financial performance, strategic growth initiatives, and positive earnings call sentiment. These strengths are partly offset by weaker names such as Etsy and ViaSat, where profitability challenges, high leverage, and bearish technical signals introduce more risk. The main risk factor is the ETF’s focus on small-cap growth companies, which can be more volatile and sensitive to valuation and cash flow pressures than larger, more established firms.
IJT vs. SPDR S&P 500 ETF (SPY)
- AUM
- 7.45B
- Region
- North America
- Expense Ratio
- 0.18%
- Beta
- 0.94
- Issuer
- iShares
- Inception Date
- Jul 24, 2000
- Dividend Yield
- 0.76%
- Asset Class
- Equity
- Index Tracked
- S&P Small Cap 600 Growth
IJT Summary
IJT is the iShares S&P Small-Cap 600 Growth ETF, which follows the S&P Small Cap 600 Growth index. It invests in smaller U.S. companies that are growing quickly, across areas like technology, healthcare, and consumer businesses. The fund holds many stocks, including well-known names like Etsy and ViaSat, giving investors broad diversification in the small-company growth space. Someone might invest in IJT if they’re looking for long-term growth potential from up-and-coming businesses. A key risk is that small-cap growth stocks can be more volatile, so the ETF’s price can move up and down more sharply than the overall market.
How much will it cost me?
IJT has an expense ratio of 0.18%, which means you’ll pay about $1.80 per year for every $1,000 invested. This cost is slightly higher than the cheapest broad-market index ETFs but still reasonable, because it tracks a more specialized small-cap growth index rather than a simple large-cap market benchmark.
What would affect this ETF?
IJT could benefit if the U.S. economy grows steadily, interest rates eventually ease, and innovation in areas like technology, healthcare, and consumer spending continues to support small, fast-growing companies such as Protagonist Therapeutics, Etsy, and ViaSat. On the other hand, higher-for-longer interest rates, an economic slowdown in the U.S., or tighter regulations on healthcare and tech firms could hurt small-cap growth stocks and make this ETF more volatile.
IJT Top 10 Holdings
IJT is leaning into U.S. small-cap growth, with a clear tilt toward innovative health care and tech names. Glaukos has been one of the fund’s real engines lately, rising steadily and giving the portfolio a strong medical-tech heartbeat, while TG Therapeutics and Protagonist Therapeutics add more biotech fuel with generally rising share prices. On the consumer side, Etsy has bounced back and is helping performance, even as its fundamentals look a bit shaky. Offsetting these winners, industrial names like Armstrong World and Zurn Water Solutions have been lagging, slightly dragging on returns.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 VSAT | ViaSat | 1.23% | $92.00M | $10.61B | 86.11% | 56Neutral |
 GKOS | Glaukos | 1.17% | $87.51M | $14.07B | 170.93% | 61Neutral |
 PTGX | Protagonist Therapeutics | 1.09% | $81.27M | $9.37B | 77.27% | 68Neutral |
 RHP | Ryman | 1.11% | $82.96M | $9.09B | 55.22% | 66Neutral |
 TGTX | TG Therapeutics | 1.02% | $76.63M | $9.36B | 72.37% | 65Neutral |
 ALKS | Alkermes | 0.91% | $67.86M | $7.61B | 46.22% | 80Outperform |
 ETSY | Etsy | 0.95% | $71.11M | $7.67B | 49.11% | 57Neutral |
 AWI | Armstrong World | 0.87% | $65.16M | $6.96B | -10.15% | 77Outperform |
 FSS | Federal Signal | 0.86% | $64.36M | $6.87B | -0.86% | 76Outperform |
 ZWS | Zurn Water Solutions | 0.79% | $59.42M | $7.40B | -5.18% | 79Outperform |
IJT Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IJT, the sentiment is Positive. The current price of 165.26 is above the 20-day moving average (MA) of 162.28, above the 50-day MA of 164.51, and above the 200-day MA of 161.16, indicating a bullish trend. The MACD of 0.17 indicates Negative momentum. The RSI at 56.10 is Neutral, neither overbought nor oversold. The STOCH value of 76.10 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IJT.
IJT Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| IJT | $165.26 | $182.00(10.13% Upside) | $7.45B | 0.18% | 68Neutral |
 FNDA | $36.36 | $43.28(19.03% Upside) | $8.91B | 0.25% | 68Neutral |
 SLYG | $110.29 | $137.61(24.77% Upside) | $4.77B | 0.15% | 68Neutral |
 VTWG | $254.47 | $378.39(48.70% Upside) | $1.41B | 0.06% | 61Neutral |
 FYC | $112.85 | $151.14(33.93% Upside) | $1.35B | 0.70% | 61Neutral |
 VIOG | $142.33 | $177.96(25.03% Upside) | $1.05B | 0.10% | 68Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IJT | iShares S&P Small-Cap 600 Growth ETF | 165.26 | 28.25 | 20.62% | |
| FNDA | Schwab Fundamental US Small Co. Index ETF | 36.36 | 6.42 | 21.45% | |
| SLYG | SPDR S&P 600 Small Cap Growth ETF | 110.29 | 18.83 | 20.59% | |
| VTWG | Vanguard Russell 2000 Growth ETF | 254.47 | 21.48 | 9.22% | |
| FYC | First Trust Small Cap Growth AlphaDEX Fund | 112.85 | 20.26 | 21.88% | |
| VIOG | Vanguard S&P Small-Cap 600 Growth ETF | 142.33 | 24.42 | 20.71% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.